Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
460.82
+4.13 (0.90%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Vertex Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
116,698115,149103,454104,85474,22055,884
Market Cap Growth
-5.39%11.30%-1.33%41.27%32.81%-9.02%
Enterprise Value
104,907110,38898,88294,36364,25449,246
Last Close Price
460.82453.36402.70406.89288.78219.60
PE Ratio
29.9929.59-193.6129.2922.5324.37
Forward PE
23.9722.6122.6624.4418.8316.42
PEG Ratio
0.170.151.211.920.581.62
PS Ratio
9.609.599.3910.628.317.38
PB Ratio
6.216.176.305.965.335.53
P/TBV Ratio
6.376.276.336.035.385.65
P/FCF Ratio
36.0736.05-130.9031.4218.9123.20
P/OCF Ratio
31.7231.71-210.0229.6417.9721.14
EV/Sales Ratio
8.749.208.979.567.196.50
EV/EBITDA Ratio
21.5625.18-3847.5523.5114.4216.94
EV/EBIT Ratio
22.3826.45-424.5724.6214.9217.70
EV/FCF Ratio
32.8534.56-125.1228.2816.3720.45
Debt / Equity Ratio
0.100.100.090.040.060.09
Debt / EBITDA Ratio
0.420.42-60.090.180.180.31
Debt / FCF Ratio
0.580.58-1.950.220.210.37
Net Debt / Equity Ratio
-0.25-0.25-0.28-0.60-0.72-0.66
Net Debt / EBITDA Ratio
-1.09-1.09177.88-2.61-2.24-2.28
Net Debt / FCF Ratio
-1.49-1.495.79-3.14-2.54-2.76
Asset Turnover
0.500.500.490.480.570.60
Inventory Turnover
1.141.141.572.102.662.85
Quick Ratio
2.242.242.173.604.464.04
Current Ratio
2.902.902.693.994.834.46
Return on Equity (ROE)
22.54%22.54%-3.15%22.99%27.67%24.93%
Return on Assets (ROA)
14.75%14.75%2.22%15.49%21.41%18.95%
Return on Invested Capital (ROIC)
24.66%24.66%4.62%47.15%75.33%63.08%
Return on Capital Employed (ROCE)
20.48%20.48%-1.22%22.16%32.27%26.29%
Earnings Yield
3.43%3.38%-0.52%3.41%4.44%4.10%
FCF Yield
2.77%2.77%-0.76%3.18%5.29%4.31%
Buyback Yield / Dilution
1.96%1.96%1.42%0.50%-0.02%2.61%
Updated Feb 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q